Block announced it’s selling its Cash App Score to third-party lenders. It could be one of the more interesting ...
EET Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096 Funding to support ...
Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson's disease, following completion of study preparations Espoo, Finland, 19 February 2026: Herantis Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results